The treatment of pterygium
LW Hirst - Survey of ophthalmology, 2003 - Elsevier
The treatment of pterygium is still quite controversial, with various treatments being
advocated in the scientific literature. Unfortunately, there are very few well-conducted …
advocated in the scientific literature. Unfortunately, there are very few well-conducted …
[HTML][HTML] Scleritis: Differentiating infectious from non-infectious entities
SI Murthy, S Sabhapandit, S Balamurugan… - Indian Journal of …, 2020 - journals.lww.com
Scleritis is a rare painful ocular disorder, associated with severe ocular pain and tissue
destruction. Although a majority of these cases are immune mediated and at least half of …
destruction. Although a majority of these cases are immune mediated and at least half of …
Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment
DHK Ma, LC See, SB Liau, RJF Tsai - British journal of ophthalmology, 2000 - bjo.bmj.com
AIM To study the efficacy and safety of amniotic membrane graft as an adjunctive therapy
after removal of primary pterygium, and to compare the clinical outcome with conjunctival …
after removal of primary pterygium, and to compare the clinical outcome with conjunctival …
[HTML][HTML] Post-operative aspergillosis
AC Pasqualotto, DW Denning - Clinical microbiology and infection, 2006 - Elsevier
While invasive aspergillosis occurs typically in severely immunocompromised patients,
cases of surgical site infection have been reported in immunocompetent individuals. The …
cases of surgical site infection have been reported in immunocompetent individuals. The …
Mitomycin: clinical applications in ophthalmic practice
LM Abraham, D Selva, R Casson, I Leibovitch - Drugs, 2006 - Springer
Mitomycin (mitomycin C; MMC) is an antibiotic isolated from Streptomyces caespitosus. The
drug is a bioreductive alkylating agent that undergoes metabolic reductive activation, and …
drug is a bioreductive alkylating agent that undergoes metabolic reductive activation, and …
Nontuberculous mycobacterial ocular and adnexal infections
RS Moorthy, S Valluri, NA Rao - Survey of ophthalmology, 2012 - Elsevier
The nontuberculous (also called “atypical”) mycobacteria have become increasingly
important causes of systemic as well as ocular morbidity in recent decades. All ocular …
important causes of systemic as well as ocular morbidity in recent decades. All ocular …
Nontuberculous mycobacterial ocular infections: a systematic review of the literature
WJ Kheir, H Sheheitli, M Abdul Fattah… - BioMed Research …, 2015 - Wiley Online Library
Nontuberculous or atypical mycobacterial ocular infections have been increasing in
prevalence over the past few decades. They are known to cause periocular, adnexal, ocular …
prevalence over the past few decades. They are known to cause periocular, adnexal, ocular …
Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneoscleral ulcers
DHK Ma, SF Wang, WY Su, RJF Tsai - Cornea, 2002 - journals.lww.com
Purpose. To study the efficacy and safety of using cryopreserved human amniotic membrane
(AM) graft as a patch graft to reduce stromal melting and promote reepithelialization in …
(AM) graft as a patch graft to reduce stromal melting and promote reepithelialization in …
Management of primary and recurrent pterygium using amniotic membrane transplantation
SE Ti, SCG Tseng - Current opinion in ophthalmology, 2002 - journals.lww.com
This review discusses the relative merits of the various techniques used in pterygium
surgery with particular reference to the growing interest in the use of amniotic membrane …
surgery with particular reference to the growing interest in the use of amniotic membrane …
Treatment and management of scleral disorders
Scleral inflammatory disorders, with their extensive differential diagnoses and sometimes as
controversial treatment options, pose both diagnostic and clinical challenges for physicians …
controversial treatment options, pose both diagnostic and clinical challenges for physicians …